Senior insider sale
Chief Medical Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$93.8K
3.47K shares
What this filing means
FOFF ERIN PENNOCK plans to sell 3.47K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $93.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001974158-26-000044
Officer· Chief Medical Officer
Since Feb 2026
3.47K
Shares to sell
$93.8K
Approx. market value
11.24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Unit Grant
N/A
5/2/2024
6.35KRestricted Stock Unit Grant
N/A
11/9/2023
1.54KRestricted Stock Unit Grant
N/A
7/30/2023
3.35KTotal acquired11.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/2/2024 | Restricted Stock Unit Grant N/A | 6.35K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 1.54K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 3.35K | — |
| Total | 11.24K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.47K
Market value
$93.8K
4/15/2026
Total
Units
3.47K
Value
$93.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/15/2026 | 3.47K | $93.8K | NASDAQ | Planned |
| Total | 3.47K | $93.8K | ||